Difficulty: Medium
Average Score: 80%
Practice
A 55-year-old woman with insulin-dependent diabetes of 40 years' duration complains of severe bloating and abdominal distress, especially after meals. Evaluation is consistent with diabetic gastroparesis. The drug you would be most likely to recommend is
Correct answer
D
Rationale
In the case of a 55-year-old woman with insulin-dependent diabetes and diabetic gastroparesis, the most appropriate drug to recommend is Metoclopramide (Option D).
Metoclopramide is a prokinetic agent that enhances gastrointestinal motility by stimulating the muscles in the upper digestive tract. This is particularly beneficial in gastroparesis, a condition characterized by delayed stomach emptying, which can lead to symptoms like bloating and abdominal distress after meals. By improving gastric emptying, Metoclopramide can alleviate these symptoms and improve overall gastrointestinal function in patients with diabetic gastroparesis.
Now, let's explore why the other options are not the best choices in this scenario:
A) Docusate is a stool softener commonly used to treat constipation by increasing the water content in the stool. It is not indicated for diabetic gastroparesis and would not address the underlying cause of the symptoms described in the case.
B) Dopamine is not a recommended treatment for diabetic gastroparesis. In fact, dopamine antagonists like Metoclopramide are more commonly used to manage this condition by enhancing gastric motility.
C) Loperamide is an anti-diarrheal medication that slows down bowel movements. While it can be helpful in conditions like diarrhea, it is not the appropriate choice for diabetic gastroparesis, which is characterized by delayed gastric emptying and bloating after meals.
In an educational context, understanding the rationale behind selecting the most appropriate medication for a specific condition is crucial for healthcare professionals. By grasping the pharmacological mechanisms of drugs like Metoclopramide and their applications in clinical scenarios such as diabetic gastroparesis, practitioners can make informed decisions to optimize patient care and outcomes.
Metoclopramide is a prokinetic agent that enhances gastrointestinal motility by stimulating the muscles in the upper digestive tract. This is particularly beneficial in gastroparesis, a condition characterized by delayed stomach emptying, which can lead to symptoms like bloating and abdominal distress after meals. By improving gastric emptying, Metoclopramide can alleviate these symptoms and improve overall gastrointestinal function in patients with diabetic gastroparesis.
Now, let's explore why the other options are not the best choices in this scenario:
A) Docusate is a stool softener commonly used to treat constipation by increasing the water content in the stool. It is not indicated for diabetic gastroparesis and would not address the underlying cause of the symptoms described in the case.
B) Dopamine is not a recommended treatment for diabetic gastroparesis. In fact, dopamine antagonists like Metoclopramide are more commonly used to manage this condition by enhancing gastric motility.
C) Loperamide is an anti-diarrheal medication that slows down bowel movements. While it can be helpful in conditions like diarrhea, it is not the appropriate choice for diabetic gastroparesis, which is characterized by delayed gastric emptying and bloating after meals.
In an educational context, understanding the rationale behind selecting the most appropriate medication for a specific condition is crucial for healthcare professionals. By grasping the pharmacological mechanisms of drugs like Metoclopramide and their applications in clinical scenarios such as diabetic gastroparesis, practitioners can make informed decisions to optimize patient care and outcomes.